A detailed history of Bruce G. Allen Investments, LLC transactions in Novartis Ag stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 2,694 shares of NVS stock, worth $278,936. This represents 0.24% of its overall portfolio holdings.

Number of Shares
2,694
Previous 2,524 6.74%
Holding current value
$278,936
Previous $269 Million 15.32%
% of portfolio
0.24%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$106.13 - $120.89 $18,042 - $20,551
170 Added 6.74%
2,694 $310 Million
Q2 2024

Jul 12, 2024

SELL
$92.57 - $107.37 $27,030 - $31,352
-292 Reduced 10.37%
2,524 $269 Million
Q1 2024

Apr 10, 2024

BUY
$95.27 - $108.47 $4,668 - $5,315
49 Added 1.77%
2,816 $272 Million
Q4 2023

Jan 10, 2024

BUY
$92.27 - $101.54 $255,311 - $280,961
2,767 New
2,767 $279 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Bruce G. Allen Investments, LLC Portfolio

Follow Bruce G. Allen Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce G. Allen Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bruce G. Allen Investments, LLC with notifications on news.